🇺🇸 Investigational Medicinal Product in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 10

Most-reported reactions

1. Abdominal Pain — 1 report (10%)
2. Bronchopneumonia — 1 report (10%)
3. Chest Pain — 1 report (10%)
4. Dizziness — 1 report (10%)
5. Haemoglobin Decreased — 1 report (10%)
6. Hallucination, Auditory — 1 report (10%)
7. Hepatitis Acute — 1 report (10%)
8. Hiccups — 1 report (10%)
9. Kidney Infection — 1 report (10%)
10. Nausea — 1 report (10%)

Source database →

Frequently asked questions

Is Investigational Medicinal Product approved in United States?

Investigational Medicinal Product does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Investigational Medicinal Product in United States?

Imperial College London is the originator. The local marketing authorisation holder may differ — check the official source linked above.